http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1167514_PMID25282263

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312361040_AID1167514_PMID25282263_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312361041_AID1167514_PMID25282263_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID1167514_PMID25282263_VALUE1
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID312361039_AID1167514_PMID25282263_VALUE2
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Modulatory activity at P-gp assessed as MDR-reversing activity by measuring potentiation of doxorubicin IC50 in human K562/DOX cells at 3 uM after 72 hrs by MTT assay relative to untreated control
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312361041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312361040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID312361039
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1167514

Total number of triples: 13.